Novartis profits jump 12% on new drug sales

Zurich, February 2015 – Swiss pharmaceuticals giant Novartis said Tuesday strong sales of new products helped push its net profit up 12 percent last year despite harsh competition from cheaper copycat generic drugs.

During 2014, the Basel-based company said its net profit rose to $12.7 billion, while sales rose one percent year-on-year to $57.9 billion.

The results were largely in line with expectations, with analysts polled by the AWP financial news agency anticipating a net profit of $12.7 billion on sales of $58.1 billion.

“2014 was a transformational year for Novartis,” the group’s chief executive Joseph Jimenez said in the earnings statement.

Sales in the company’s core pharmaceuticals division slipped one percent once converted to dollars, but inched up one percent in constant currencies, to $31.8 billion.

Volumes in this division rose seven percent while prices saw a one percent hike, the company said.

This helped offset losses from sales of competing cheaper generic drugs. Novartis’s blood pressure pill Diovan is facing stiff competition from a cheaper variant produced by Indian firm Ranbaxy.

“We delivered solid sales growth with margin expansion, strengthened innovation, and advanced our quality and productivity agendas. I’m confident that we are positioned for future success,” Jimenez said.

The company is banking on new offerings such as an anti-heart failure treatment LCZ696 to help ward off competition from generics.

Novartis forecast a sales increase of five percent for this year at constant currencies and said it hoped a sweeping asset swap with British giant GlaxoSmithKline would be concluded by March 31.

The deal will see Novartis acquiring GSK’s oncology products while divesting its vaccines to the British group and creating a joint unit for consumer health products.

The company said it would raise dividend to 2.60 Swiss francs per share for 2014, a six percent growth over the previous year. Business Line

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

1 day ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

1 day ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

2 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

2 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

3 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

3 days ago